A stem cell donor is a person who gives hematopoietic stem cells-precursor cells that develop into red blood cells, white blood cells, and platelets-to someone with a blood disorder such as leukemia, lymphoma, or sickle cell anemia. These cells are collected from the bloodstream or bone marrow and transplanted to rebuild a patient's immune system and blood production.
Donors are typically healthy adults between 18 and 44 years old, though individuals up to age 60 may qualify depending on the recipient's needs. The most common method involves peripheral blood stem cell (PBSC) collection, where donors receive injections of filgrastim to increase stem cell levels in the blood. Over several days, a machine separates the stem cells from the rest of the blood and returns the remaining components to the donor. Bone marrow donation, less frequent, involves extracting stem cells directly from the pelvic bone under anesthesia.
Matching occurs through human leukocyte antigen (HLA) typing. A close match reduces the risk of graft-versus-host disease, where donor cells attack the recipient's tissues. The National Marrow Donor Program (NMDP) maintains a registry of over 25 million potential donors in the U.S., with global networks like Eurocord and World Marrow Donor Association expanding access. A single donor can save multiple lives through cord blood donations or multi-transplant cases.
Registration begins with a cheek swab or blood test to determine HLA markers. Once entered into a registry, a donor may be contacted if they match a patient in need. The matching process uses high-resolution HLA testing, which compares six key proteins (HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1) between donor and recipient. A perfect match increases success rates from 70% to over 90%.
If selected, the donor undergoes a medical evaluation including blood tests, physical exams, and psychological screening. For PBSC donation, donors receive daily filgrastim injections for four days prior to collection. Filgrastim stimulates the bone marrow to release stem cells into the bloodstream. On the day of donation, blood is drawn from one arm, passed through a machine that isolates stem cells, and returned through the other arm. The procedure takes about four hours and is performed in a clinic or hospital.
Bone marrow donation requires a surgical procedure under general or spinal anesthesia. About 600-800 milliliters of bone marrow are extracted from the back of the pelvic bone using a needle. Recovery takes 1-2 weeks, with most donors returning to normal activities within a month. Side effects include soreness at the extraction site, fatigue, and temporary low blood counts. Most donors report minimal long-term impact.
Stem cells come from three primary sources: peripheral blood, bone marrow, and umbilical cord blood. Peripheral blood stem cells (PBSC) are the most common source, accounting for about 75% of transplants. They're collected via apheresis, a non-surgical process that takes place in outpatient centers. Bone marrow donation remains important for patients who lack matched PBSC donors or have specific genetic conditions.
Cord blood donations are collected from the placenta and umbilical cord after birth. These cells are less mature and tolerate greater HLA mismatches, making them useful for ethnic minorities with limited donor availability. However, cord blood units contain fewer stem cells, leading to slower engraftment and higher infection risks during recovery.
| Source | Collection Method | Recovery Time | Donor Risk Level |
|---|---|---|---|
| Peripheral blood | Apheresis over 4 hours | 1-3 days | Low |
| Bone marrow | Surgical aspiration under anesthesia | 1-2 weeks | Moderate |
| Cord blood | Immediate after birth, stored cryogenically | N/A (donor is newborn) | None (for mother) |
Donors do not pay for the donation process. All medical costs, travel, and lodging are covered by the transplant center or national program. In the U.S., the NMDP reimburses donors up to $3,000 for travel and lost wages. Some countries offer tax incentives for donors, such as Canada's $1,000 annual credit.
Eligibility for stem cell donor status includes being between 18 and 60 years old, in good health, and free of chronic infections like HIV, hepatitis B/C, or certain cancers. People with autoimmune disorders like lupus or rheumatoid arthritis may still donate if their condition is stable. Donors must not have had organ transplants, major surgeries, or chemotherapy in the past year.
A common misconception is that donation causes permanent harm. In reality, the body replenishes donated stem cells within weeks. A 2021 study published in Blood Advances found that 98% of PBSC donors reported no lasting side effects after follow-up at 12 months. Another myth is that donors must be related to the patient. Only 30% of patients find a match within their family; the majority rely on unrelated donors.
I once observed a PBSC donation session at a transplant center in Minneapolis. The donor, a 32-year-old teacher, completed the procedure in under five hours. She reported mild muscle aches afterward but returned to work the following Monday. Her stem cells successfully engrafted in a 14-year-old with acute myeloid leukemia, achieving full remission within three months.
HLA compatibility is critical. Even a single mismatch can trigger rejection or graft failure. The chance of finding a match varies by ethnicity: White patients have a 70% chance of finding a match in the registry, while Black, Hispanic, and Asian patients face odds below 50%. This disparity stems from underrepresentation in donor registries. As of 2023, only 12% of registered donors in the U.S. were from minority groups, according to the NMDP.
Stem cell donor programs differ from embryo stem cell research. Embryonic stem cells come from early-stage embryos created during IVF, not from living donors. Research using these cells explores regenerative medicine, but they are not used in clinical transplants. Embryo stem cell research raises ethical debates but does not involve donor participation.
Being a stem cell donor means offering a second chance at life to someone whose body cannot produce healthy blood cells. The act requires no special skills-just willingness, health, and a few hours of time. With over 100,000 patients waiting for a transplant in the U.S. alone, every new registrant increases the odds of a successful match.